Viewing nowClothens Tablets (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

MFDS item code 201507899 · Approved 2015.11.25 · Insurance code 669501650
Improves symptoms of atherosclerosis and acute coronary syndrome; prevents thrombi in atrial fibrillation
This medication is used to improve symptoms of atherosclerosis in adult patients suffering from ischemic stroke, myocardial infarction, or peripheral artery disease. Additionally, it helps reduce the risk of death, myocardial infarction, stroke, or severe ischemic symptoms due to cardiovascular events in patients with acute coronary syndrome (unstable angina or non-ST elevation myocardial infarction) who have received drug treatment, coronary intervention, or coronary artery bypass. Furthermore, it serves to decrease the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors but for whom vitamin K antagonists are not suitable. This drug is used to promote vascular health and prevent serious vascular complications.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.
This drug prevents the aggregation of platelets in the blood to prevent the formation of clots. It must be converted into its active form by a specific enzyme in the liver, CYP2C19, to be effective. Individuals who genetically have reduced function of this enzyme may experience diminished efficacy, so it is advisable to consult a physician. Taking this medication with drugs that activate the CYP2C19 enzyme can increase the concentration of the active metabolite and may elevate the risk of bleeding, so co-administration should be avoided. Patients with allergies to this medication, those with bleeding, individuals with severe liver disease, breastfeeding women, and those with lactose intolerance should not take this drug. Patients at risk of bleeding or with abnormalities in blood coagulation, those scheduled for surgery, elderly patients, and underweight individuals should use this medication cautiously, and report any signs of bleeding to a physician immediately. Since this drug can cause bleeding, it is crucial to undergo tests if symptoms of bleeding occur or if abnormalities are found in blood tests. Additionally, caution is necessary when combined with other medications that carry a bleeding risk. During the course of treatment, bleeding may take longer to stop, so it is crucial to inform medical personnel before any surgery or dental treatment. Rarely, thrombocytopenia or severe blood adverse reactions may occur, thus patients with fever or symptoms of infection should visit a hospital promptly. Side effects may include gastrointestinal disorders, diarrhea, rash, headache, dizziness, and abdominal pain. If pregnant, the effects of this medication on the fetus are minimal; however, due to the risk of bleeding during delivery, consultation with medical personnel is necessary. During breastfeeding, this medication may pass into breast milk, and it is essential to consult with a doctor regarding continuation or discontinuation of breastfeeding. This drug may increase the risk of bleeding in the event of an overdose, and since there is no antidote, treatments such as platelet transfusions may be necessary in cases of severe bleeding. Keep this medication out of reach of children and do not transfer it to other containers for safety. While taking this medication, it is important to routinely visit a physician to reduce the risk of bleeding and always consult with medical personnel regarding interactions with other medications being taken.
Hemorrhage, gastrointestinal bleeding, hospitalization required for bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major bleeding, life-threatening bleeding, fatal bleeding, hemorrhagic stroke, need for transfusion, functional impairment, vision loss, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, gastrointestinal symptoms, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, depression, upper respiratory infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, constipation, vomiting, hypercholesterolemia, arthralgia, low back pain, depression, insomnia, anxiety, blood in stool, thrombocytopenia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergic symptoms, ischemic necrosis, hemorrhagic gastritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, distension, bilirubinemia, infectious hepatitis, fatty liver, thrombocytopenia, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, petechial eruption, erythema, urticaria, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This helps to maintain the drug's effectiveness over a longer period.
Pink, round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.